Literature DB >> 11352877

Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

J Danesh1, P Whincup, M Walker, L Lennon, A Thomson, P Appleby, A Rumley, G D Lowe.   

Abstract

BACKGROUND: It is unknown whether modest increases of fibrin D-dimer, a circulating marker of fibrin turnover, are relevant to coronary heart disease (CHD) in the general population. METHODS AND
RESULTS: We measured serum concentrations of D-dimer antigen in the stored baseline blood samples of 630 CHD cases and 1269 controls "nested" in a prospective cohort of 5661 men who were monitored for 16 years, and we conducted a meta-analysis of previous relevant studies to place our findings in context. In a comparison of men in the top third compared with those in the bottom third of baseline fibrin D-dimer values (tertile cutoffs, >94 versus <49 ng/mL), the odds ratio for CHD was 1.67 (95% CI, 1.31 to 2.13; P<0.0001) after adjustments for age and town. The odds ratio increased slightly after further adjustment for smoking, other classic risk factors, and indicators of socioeconomic status (1.79; 95% CI, 1.36 to 2.36). Strong correlations were observed of fibrin D-dimer values with circulating concentrations of C-reactive protein and serum amyloid A protein but not with smoking, blood lipids, blood pressure, and other risk factors.
CONCLUSION: Although there may be an association between circulating D-dimer values and CHD, further studies are needed to determine the extent to which this is causal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352877     DOI: 10.1161/01.cir.103.19.2323

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  78 in total

Review 1.  Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease.

Authors:  Roland von Känel; Joel E Dimsdale
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

2.  Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.

Authors:  L Maria Belalcazar; Christie M Ballantyne; Wei Lang; Steven M Haffner; Julia Rushing; Dawn C Schwenke; F Xavier Pi-Sunyer; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-21       Impact factor: 8.311

3.  Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity.

Authors:  Abdullah Dogan; Bahattin Tunc; Oktay Ergene; Mehmet Ozaydin; Cem Nazli; Ahmet Altinbas; Omer Gedikli
Journal:  Int J Cardiovasc Imaging       Date:  2003-12       Impact factor: 2.357

Review 4.  Role of fibrin D-dimer testing in emergency medicine.

Authors:  A Wakai; A Gleeson; D Winter
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

Review 5.  Measurement of thrombosis and its prevention.

Authors:  Gordon D O Lowe
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 6.  Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010.

Authors:  James D Neaton; Jacqueline Neuhaus; Sean Emery
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

7.  Day/Night rhythm of hemostatic factors in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; José S Loredo; Joel E Dimsdale
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

8.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

9.  Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls.

Authors:  Roland von Känel; Sonia Ancoli-Israel; Joel E Dimsdale; Paul J Mills; Brent T Mausbach; Michael G Ziegler; Thomas L Patterson; Igor Grant
Journal:  Gerontology       Date:  2009-12-03       Impact factor: 5.140

10.  High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

Authors:  Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.